The broad clinical phenotype of Type 1 diabetes at presentation
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Immune‐mediated (auto‐immune) Type 1 diabetes mellitus is not a homogenous entity, but nonetheless has distinctive characteristics. In children, it may present with classical insulin deficiency and ketoacidosis at disease onset, whereas autoimmune diabetes in adults may not always be insulin dependent. Indeed, as the adult‐onset form of autoimmune diabetes may resemble Type 2 diabetes, it is imperative to test for diabetes‐associated autoantibodies to establish the correct diagnosis. The therapeutic response can be predicted by measuring the levels of autoantibodies to various islet cell autoantigens, such as islet cell antibodies (ICA), glutamate decarboxylase 65 (GAD 65), insulin, tyrosine phosphatase (IA‐2) and IA‐2β, and zinc transporter 8 (ZnT8) and evaluating β‐cell function. A high risk of progression to insulin dependency is associated with particular genetic constellations, such as human leukocyte antigen risk alleles, young age at onset, the presence of multiple autoantibodies, including high titres of anti‐GAD antibodies; such patients should be offered early insulin replacement therapy, as they respond poorly to diet and oral hypoglycaemic drug therapy. Hence, considering the broad spectrum of phenotypes seen in adult‐onset diabetes, treatment targets can only be reached by identification of immune‐mediated cases, as their management differs from those with classical Type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
�ber den anschaulichen Inhalt der quantentheoretischen Kinematik und Mechanik
Heisenberg, W. (1927) · Zeitschrift f�r Physik · doi:10.1007/bf01397280 · Cited by 4,278
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group
Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
Steffes, M. W., Sibley, S., Jackson, M., & Thomas, W. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.832 · Cited by 695
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Skrivarhaug, T., Bangstad, H.-J., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0082-6 · Cited by 390
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Cited by
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Body temperature regulation in diabetes
Kenny, G. P., Sigal, R. J., & McGinn, R. (2016) · Temperature · doi:10.1080/23328940.2015.1131506 · Cited by 297
“Diabetes care plans must consider adjustments for the age-related changes in functional status and incorporate appropriate accommodations for individuals who may be less able to manage their glycemia.(42) Furthermore, the earlyonset of type 1 diabetes results in a longer burden of disease, and therefore increased diab…”
BackgroundHumphreys, A., Bravis, V., Kaur, A., Walkey, H. C., Godsland, I. F., Misra, S., Johnston, D. G., & Oliver, N. S. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107789 · Cited by 28
Mottalib, A., Tomah, S., Hafida, S., Elseaidy, T., Kasetty, M., Ashrafzadeh, S., & Hamdy, O. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13478 · Cited by 15
“The difference may be related to the use of intensive insulin therapy, which was previously shown to promote weight gain in patients with T1D.3 Although the degree of change in HbA1c did not differ between cohorts at 12 months, there was a modest, yet significant, improvement in glycaemic control compared to baseline…”
BackgroundInfluential
Metadata
- Authors
- Merger, S. R., Leslie, R. D., & Boehm, B. O.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2013-01-21
- Volume
- 30
- Issue
- 2
- Pages
- 170-178
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2143260423
- Cited by
- 68
- References
- 26
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The broad clinical phenotype of Type 1 diabetes at presentation. https://app.cochat.ai/papers/10.1111/dme.12048
- The paper
- Merger, S. R., Leslie, R. D., & Boehm, B. O. (2013). The broad clinical phenotype of Type 1 diabetes at presentation. Diabetic Medicine. https://doi.org/10.1111/dme.12048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.